AgeX Therapeutics

Serina Therapeutics, M&A, AgeX Therapeutics, Parkinson disease,

Serina Therapeutics merges with struggling AgeX Therapeutics to go public and advance its Parkinson’s drug

Anika Sharma

AgeX Therapeutics, a biotech that has been facing financial difficulties and stalled preclinical programs for years, has finally found a ...